Prothena Corporation PLCNASDAQ:PRTA
- LAST PRICE35.2300
- TODAY'S CHANGE (%)-0.2000 (-0.5645%)
- Bid / Lots32.0000/ 4
- Ask / Lots50.4500/ 3
- Open / Previous Close34.9500 / 35.4300
- Day Range
- 52 Week Range
- Volume484,940
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRTA |
|---|---|---|
| 09:32 ET | 15727 | 36.12 |
| 09:37 ET | 200 | 36.425 |
| 09:39 ET | 1015 | 35.98 |
| 09:42 ET | 310 | 35.98 |
| 09:46 ET | 700 | 35.74 |
| 09:48 ET | 751 | 36.5 |
| 09:50 ET | 300 | 35.85 |
| 09:51 ET | 1375 | 36.175 |
| 09:55 ET | 2509 | 35.765 |
| 09:57 ET | 200 | 35.89 |
| 10:00 ET | 1495 | 36.415 |
| 10:02 ET | 400 | 36.01 |
| 10:04 ET | 800 | 35.6 |
| 10:06 ET | 400 | 35.83 |
| 10:08 ET | 500 | 35.81 |
| 10:09 ET | 100 | 35.57 |
| 10:11 ET | 800 | 35.4 |
| 10:13 ET | 407 | 35.32 |
| 10:15 ET | 3200 | 35.51 |
| 10:18 ET | 300 | 35.15 |
| 10:20 ET | 1075 | 35.165 |
| 10:22 ET | 2490 | 35.165 |
| 10:24 ET | 1600 | 35.205 |
| 10:26 ET | 1834 | 35.645 |
| 10:27 ET | 3072 | 36.09 |
| 10:29 ET | 400 | 35.8 |
| 10:31 ET | 455 | 36.02 |
| 10:33 ET | 600 | 35.9371 |
| 10:36 ET | 500 | 36.295 |
| 10:38 ET | 900 | 36.45 |
| 10:40 ET | 2600 | 36.16 |
| 10:42 ET | 2026 | 36.06 |
| 10:44 ET | 500 | 36.065 |
| 10:45 ET | 700 | 36.175 |
| 10:47 ET | 700 | 36.26 |
| 10:49 ET | 2112 | 36.49 |
| 10:51 ET | 1500 | 36.72 |
| 10:54 ET | 1100 | 36.395 |
| 10:56 ET | 300 | 36.445 |
| 10:58 ET | 1418 | 36.5082 |
| 11:00 ET | 800 | 36.37 |
| 11:02 ET | 400 | 36.31 |
| 11:03 ET | 1500 | 36.32 |
| 11:05 ET | 600 | 36.23 |
| 11:07 ET | 800 | 36.48 |
| 11:09 ET | 900 | 36.55 |
| 11:12 ET | 900 | 36.37 |
| 11:14 ET | 100 | 36.32 |
| 11:16 ET | 500 | 36.27 |
| 11:18 ET | 950 | 36.265 |
| 11:20 ET | 300 | 36.16 |
| 11:21 ET | 1141 | 36.38 |
| 11:23 ET | 400 | 36.44 |
| 11:25 ET | 459 | 36.35 |
| 11:27 ET | 200 | 36.37 |
| 11:30 ET | 1180 | 36.305 |
| 11:32 ET | 500 | 36.065 |
| 11:34 ET | 300 | 36.17 |
| 11:36 ET | 1300 | 36.19 |
| 11:38 ET | 300 | 35.86 |
| 11:39 ET | 1100 | 35.7 |
| 11:41 ET | 400 | 35.75 |
| 11:43 ET | 800 | 35.82 |
| 11:45 ET | 300 | 35.82 |
| 11:48 ET | 600 | 35.8 |
| 11:50 ET | 100 | 35.805 |
| 11:52 ET | 8392 | 35.865 |
| 11:54 ET | 400 | 35.88 |
| 11:56 ET | 2007 | 35.78 |
| 11:57 ET | 2166 | 36.26 |
| 11:59 ET | 500 | 35.965 |
| 12:01 ET | 400 | 36.145 |
| 12:03 ET | 639 | 36 |
| 12:06 ET | 1602 | 36.13 |
| 12:08 ET | 686 | 36.125 |
| 12:10 ET | 500 | 35.95 |
| 12:12 ET | 600 | 35.93 |
| 12:14 ET | 10822 | 35.53 |
| 12:15 ET | 1100 | 35.43 |
| 12:17 ET | 1109 | 35.31 |
| 12:19 ET | 300 | 35.36 |
| 12:21 ET | 902 | 35.29 |
| 12:24 ET | 931 | 35.285 |
| 12:26 ET | 710 | 35.47 |
| 12:28 ET | 1613 | 35.45 |
| 12:30 ET | 300 | 35.495 |
| 12:32 ET | 900 | 35.56 |
| 12:33 ET | 100 | 35.565 |
| 12:35 ET | 1100 | 35.74 |
| 12:37 ET | 1671 | 35.42 |
| 12:39 ET | 700 | 35.52 |
| 12:42 ET | 1487 | 35.5 |
| 12:46 ET | 300 | 35.61 |
| 12:48 ET | 1077 | 35.72 |
| 12:50 ET | 1437 | 35.66 |
| 12:51 ET | 100 | 35.54 |
| 12:53 ET | 100 | 35.545 |
| 12:55 ET | 400 | 35.44 |
| 12:57 ET | 200 | 35.49 |
| 01:00 ET | 400 | 35.43 |
| 01:02 ET | 300 | 35.49 |
| 01:04 ET | 700 | 35.36 |
| 01:06 ET | 1100 | 35.385 |
| 01:08 ET | 100 | 35.38 |
| 01:11 ET | 300 | 35.59 |
| 01:15 ET | 1310 | 35.51 |
| 01:18 ET | 1700 | 35.54 |
| 01:20 ET | 500 | 35.4375 |
| 01:22 ET | 300 | 35.23 |
| 01:24 ET | 800 | 35.24 |
| 01:26 ET | 100 | 35.19 |
| 01:27 ET | 300 | 35.325 |
| 01:29 ET | 200 | 35.23 |
| 01:31 ET | 903 | 35.3 |
| 01:33 ET | 400 | 35.22 |
| 01:38 ET | 500 | 35.22 |
| 01:40 ET | 300 | 35.26 |
| 01:42 ET | 400 | 35.42 |
| 01:47 ET | 1300 | 35.29 |
| 01:49 ET | 1700 | 35.335 |
| 01:51 ET | 1174 | 35.31 |
| 01:54 ET | 300 | 35.165 |
| 01:56 ET | 300 | 35.25 |
| 01:58 ET | 300 | 35.295 |
| 02:00 ET | 200 | 35.24 |
| 02:02 ET | 200 | 35.2 |
| 02:03 ET | 200 | 35.285 |
| 02:05 ET | 500 | 35.31 |
| 02:07 ET | 600 | 35.37 |
| 02:09 ET | 800 | 35.345 |
| 02:12 ET | 100 | 35.36 |
| 02:14 ET | 900 | 35.37 |
| 02:18 ET | 600 | 35.495 |
| 02:20 ET | 1600 | 35.48 |
| 02:21 ET | 500 | 35.64 |
| 02:23 ET | 300 | 35.76 |
| 02:25 ET | 300 | 35.5525 |
| 02:27 ET | 500 | 35.41 |
| 02:30 ET | 500 | 35.29 |
| 02:32 ET | 200 | 35.34 |
| 02:34 ET | 400 | 35.34 |
| 02:36 ET | 1600 | 35.31 |
| 02:38 ET | 2500 | 35.51 |
| 02:39 ET | 2684 | 35.735 |
| 02:41 ET | 1584 | 35.89 |
| 02:43 ET | 900 | 36.025 |
| 02:45 ET | 2400 | 35.9525 |
| 02:48 ET | 800 | 35.99 |
| 02:50 ET | 308 | 36.04 |
| 02:52 ET | 400 | 36.005 |
| 02:54 ET | 200 | 35.91 |
| 02:56 ET | 1100 | 35.84 |
| 02:57 ET | 1030 | 35.72 |
| 02:59 ET | 200 | 35.705 |
| 03:01 ET | 600 | 35.64 |
| 03:03 ET | 900 | 35.635 |
| 03:06 ET | 917 | 35.48 |
| 03:08 ET | 1100 | 35.415 |
| 03:10 ET | 600 | 35.395 |
| 03:12 ET | 6240 | 35.19 |
| 03:14 ET | 1056 | 35.215 |
| 03:15 ET | 500 | 35.2492 |
| 03:17 ET | 5922 | 35.62 |
| 03:19 ET | 200 | 35.67 |
| 03:21 ET | 2066 | 35.45 |
| 03:24 ET | 700 | 35.66 |
| 03:26 ET | 400 | 35.52 |
| 03:28 ET | 500 | 35.39 |
| 03:30 ET | 300 | 35.35 |
| 03:32 ET | 9100 | 35.4 |
| 03:33 ET | 849 | 35.405 |
| 03:35 ET | 500 | 35.5 |
| 03:37 ET | 900 | 35.42 |
| 03:39 ET | 900 | 35.46 |
| 03:42 ET | 2200 | 35.655 |
| 03:44 ET | 1000 | 35.86 |
| 03:46 ET | 1900 | 35.82 |
| 03:48 ET | 2900 | 35.75 |
| 03:50 ET | 600 | 35.75 |
| 03:51 ET | 4254 | 35.37 |
| 03:53 ET | 3500 | 35.32 |
| 03:55 ET | 5298 | 35.17 |
| 03:57 ET | 13949 | 35.23 |
| 04:00 ET | 110123 | 35.23 |
Jan 6, 2022
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prothena Corporation PLC | 1.6B | 34.1x | --- |
Instil Bio Inc | 1.6B | -13.7x | --- |
Sana Biotechnology Inc | 1.6B | -4.2x | --- |
Allogene Therapeutics Inc | 1.6B | -6.1x | --- |
Verve Therapeutics Inc | 1.6B | -13.7x | --- |
Cassava Sciences Inc | 1.5B | -66.3x | --- |
Company Information
Prothena Corporation PLC is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The Company's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aβ) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.
Contact Information
- Headquarters
- 77 Sir John Rogersons Quay Block C, Grand Canal DocklandsDUBLIN, Ireland D02 T804
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Lars Ekman
- Chief Operating Officer, Chief Scientific Officer, Head - Research and Development
- Gene Kinney
- Chief Financial Officer, Chief Strategy Officer
- Tran Nguyen
- Chief Operating Officer, Chief Business Officer
- Brandon Smith
- Chief Accounting Officer, Controller
- Karin Walker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $199.8M |
Shares Outstanding | 46.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $1.03 |
Book Value | $4.61 |
P/E Ratio | 34.1x |
Price/Sales (TTM) | 8.2 |
Price/Cash Flow (TTM) | 23.2x |
Operating Margin | 37.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
